<ui-view class="container">
<p class="align-center">This is where cool news goes. <a ui-sref="news.detailed({newsId: 'synthetic'})">Test news</a></p>
<ul class="container">
	<li>
	<strong>Mar. 2017</strong> - Glycan Therapeutics has released 14 new compounds under the Biotin tag to its catalog. <a ui-sref="products.compounds({tag: 'Biotin'})">Click here</a> to check out our new line of compounds.
	</li><br>
	<li>
	<strong>Sept. 2016</strong> - Glycan Therapeutics has added 32 new compounds to its catalog. Each new compound has an Azido functional group that can be used to couple with a flourescent or affinty tag. These new compounds are only available through <a ui-sref="products.compounds({tag: 'Azido'})">Glycan Therapeutics</a>.
	</li><br>
	<li>
	<strong>Oct. 2015</strong> - Glycan Therapeutics has been awarded a SBIR phase II contract from National Institute of Cancer
	with a total budget of close to $1 million over two years. The contract has commissioned the 
	company to synthesize a library of heparan sulfate oligosaccharides for cancer-related research.
	</li>
</ul>
</ui-view>